Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Dec ‘13 |
|
|---|---|---|---|---|---|
| $50.8M | $342M | $291M | 58.5% |
|
|
| $48.8M | $77.2M | $28.5M | 174% |
|
|
| $48.2M | $128M | $80.1M | 106% |
|
|
154
Novartis
NVS
$315B
| $48M | $182M | $134M | 130% |
|
| $47.9M | $178M | $130M | 342% |
|
|
| $46.5M | $81.5M | $35M | 20.5% |
|
|
| $45.7M | $46.4M | $737K | 75.3% |
|
|
| $45.5M | $327M | $282M | 535% |
|
|
| $45.4M | $185M | $140M | 131% |
|
|
| $45.3M | $94.7M | $49.4M | 125% |
|
|
|
OSG
161
Octave Specialty Group
OSG
$237M
| $45.1M | $64.8M | $19.7M | 78% |
|
| $45M | $99.9M | $55M | 64.1% |
|
|
| $44.8M | $184M | $139M | 356% |
|
|
| $44.7M | $55.9M | $11.1M | 33.5% |
|
|
| $44.3M | $460M | $416M | 1,889% |
|
|
| $44.3M | $251M | $207M | 31.2% |
|
|
| $44.3M | $1.28B | $1.23B | 6.95% |
|
|
| $43.6M | $115M | $71.9M | 50.4% |
|
|
| $43.3M | $88.6M | $45.3M | 92.5% |
|
|
| $43M | $87.3M | $44.3M | 58.5% |
|
|
| $42.7M | $49.6M | $6.89M | 450% |
|
|
| $42.6M | $126M | $83.4M | 14.7% |
|
|
| $42.6M | $48.4M | $5.85M | 48.3% |
|
|
| $42.1M | $62.8M | $20.7M | 179% |
|
|
| $41.8M | $93.7M | $51.9M | 298% |
|